NIH starts Phase l trial of rZIKV/D4Δ30-713 for Zika virus infection
The US National Institutes of Health (NIH) has started a Phase l clinical trial of rZIKV/D4Δ30-713 vaccine for the prevention…
Zika virus NIH rZIKV/D4Δ30-713
